Archives: Resources
AI’s real role in Health Technology Assessment (HTA)
Explore how AI is shaping health technology assessment, balancing speed, rigor and trust to support better real-world evidence and decision-making
Drug Development Insights: What New Industry Data Reveals for 2026
Discover 2026 drug development trends from global industry data and learn how leaders adapt to uncertainty and evolving R&D pressures.
2026 ISG Provider Lens Report
Explore a comprehensive view of the industry’s digital service providers.
How AI Is Moving From Promise to Practice in Pharmacovigilance
AI is transitioning from theory to operational use in pharmacovigilance. Explore the opportunities, challenges, and emerging best practices driving the next phase of AI-enabled drug safety.
AI Transformation in Pharmacovigilance
Explore how AI transforms pharmacovigilance operations to improve efficiency, quality and compliance.
Precision medicine in cell and gene therapy
Learn how to navigate clinical, operational and regulatory complexities in cell and gene therapy to design adaptive, patient-centric precision medicine programs.
AI in Post-Approval Drug Safety: Effective Management of Real-World Patient Data
Explore how AI-driven pharmacovigilance improves post-market drug safety by enabling faster risk detection and optimizing compliance through scalable workflows.
How PPD™ Translate solutions ensure high-quality deliverables, on-time delivery and rapid turnaround
This white paper outlines how PPD Translate solutions deliver consistent, high-quality life sciences translations using an MSP model, AI tools, and expert quality checks.